Turnover of Plasma Glucose and Free Fatty Acids in Patients on the First Day after Myocardial Infarction

1976 ◽  
Vol 50 (5) ◽  
pp. 401-407
Author(s):  
I. A. Nimmo ◽  
R. H. Smith ◽  
M. A. Dolder ◽  
M. F. Oliver

1. The turnover of plasma glucose and free fatty acids was measured in ten patients within 24 h of the onset of symptoms of acute myocardial infarction and in two with symptoms of acute myocardial ischaemia. The measurements were repeated in seven of the patients 12–40 weeks after the acute episode. 2. Both for the patients with acute myocardial infarction alone and for all the individuals studied the turnover of glucose increased with plasma glucose concentration but was not related to the turnover of free fatty acids or the plasma concentrations of free fatty acids, insulin or total catecholamines. There was no obvious difference in the nature of the glucose turnover—concentration relationship between the patients with acute myocardial infarction, with acute myocardial ischaemia and on re-examination. 3. For all the individuals studied the turnover of free fatty acids increased with the concentration of these but was not related to the turnover of glucose or the plasma concentrations of glucose, insulin or total catecholamines. There was no obvious difference in the nature of the free fatty acids turnover—concentration relationship between the patients with acute myocardial infarction, with acute myocardial ischaemia and on re-examination.

Author(s):  
Frank Bertschat ◽  
Hartmut Ising ◽  
Theodor Günther ◽  
Allen Jeremias ◽  
Elisabeth Jeremias

1979 ◽  
Author(s):  
H. Arnesen ◽  
Ø. Skjæggestad ◽  
N. Wik

The frequency of deep vein thrombosis (DVT) diagnosed with the 125I-fibrinogen technique in patients with acute myocardial infarction (AMI) has been found to be reduced frcm about 20% without anticoagulation to about 5% with warfarin or small doses of subcutaneous heparin.A somewhat higher incidence of ventricular tachycardia in patients with AMI treated with small doses of subcutaneous heparin has been reported. A possible mechanism might be heparin-induced activation of lipoprotein lipase with consequent increase of plasma free-fatty-acids (FFA), which have been found to be arrhythmogenic in patients with AMI.In the present prospective trial, 99 patients with AMI and a history of less than 12 hours were allocated at random to treatment with subcutaneous heparin 5000 IU twice daily, or warfarin. In a randomized subsample of 21 patients fasting FFA analyses were performed before and 2 hours after the administration of anticoagulants on day 1 and 2.No measurable increase in FFA concentrations was demonstrated in the heparin-treated patients, in spite of a significant influence on the thrombin clotting time.The frequency of ventricular arrhythmias as detected by continous tape recordings was equal in the two treatment groups.It is concluded that subcutaneous heparin 5 000 IU every 12 hours seems to be a safe measures of prophylaxis against venous thromboembolic ccmplications in patients with AMI.


Author(s):  
D Fraser Davidson

Some of the initial biochemical findings, obtained from 141 randomly-selected cases of acute hyperglycaemia (admission plasma glucose >20 mmol/L) were examined. When viewed in terms of their initial plasma bicarbonate concentration, three groups were identifiable. Plasma concentrations of free fatty acids (FFA), acetone and the sum of 3-hydroxybutyrate (3OHB) and lactate were different between these groups. However, there were no differences in plasma glucose or lactate concentrations. It was further observed that the relationship between the plasma FFA/albumin molar ratio, and ketone concentration could be described by a rectangular hyperbola, and the initial anion gap was linearly related to the sum of the 3OHB and lactate concentrations.


Sign in / Sign up

Export Citation Format

Share Document